Yuanyuan Jiang

Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

AI agency drives college students' entrepreneurial thinking through human sense of agency in human and ai symbiosis.

AI agency drives college students' entrepreneurial thinking through human sense of agency in human and ai symbiosis.

Journal: Scientific reports

Published: March 27, 2026

Phosphatidylinositol 4-kinase α suppresses glioblastoma progression by inactivating YAP and PI3K/Akt signaling.

Phosphatidylinositol 4-kinase α suppresses glioblastoma progression by inactivating YAP and PI3K/Akt signaling.

Journal: The Journal of biological chemistry

Published: August 26, 2025

The effects of exogenous testosterone and facial attractiveness on men's altruistic punishment behavior.

The effects of exogenous testosterone and facial attractiveness on men's altruistic punishment behavior.

Journal: Psychoneuroendocrinology

Published: March 18, 2025

Deguelin inhibits the glioblastoma progression through suppressing CCL2/NFκB signaling pathway.

Deguelin inhibits the glioblastoma progression through suppressing CCL2/NFκB signaling pathway.

Journal: Neuropharmacology

Published: March 25, 2024

Mapping the bioimaging marker of Alzheimer's disease based on pupillary light response-driven brain-wide fMRI in awake mice.

Mapping the bioimaging marker of Alzheimer's disease based on pupillary light response-driven brain-wide fMRI in awake mice.

Journal: bioRxiv : the preprint server for biology

Published: January 08, 2024

Sophocarpine inhibits the progression of glioblastoma via PTEN/PI3K/Akt signaling pathway.

Sophocarpine inhibits the progression of glioblastoma via PTEN/PI3K/Akt signaling pathway.

Journal: American journal of cancer research

Published: December 26, 2023

Tenacissoside H repressed the progression of glioblastoma by inhibiting the PI3K/Akt/mTOR signaling pathway.

Tenacissoside H repressed the progression of glioblastoma by inhibiting the PI3K/Akt/mTOR signaling pathway.

Journal: European journal of pharmacology

Published: November 14, 2023

Columbianadin suppresses glioblastoma progression by inhibiting the PI3K-Akt signaling pathway.

Columbianadin suppresses glioblastoma progression by inhibiting the PI3K-Akt signaling pathway.

Journal: Biochemical pharmacology

Published: October 19, 2023

Dual targeting agent Thiotert inhibits the progression of glioblastoma by inducing ER stress-dependent autophagy.

Dual targeting agent Thiotert inhibits the progression of glioblastoma by inducing ER stress-dependent autophagy.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 28, 2023

Angelicin impedes the progression of glioblastoma via inactivation of YAP signaling pathway.

Angelicin impedes the progression of glioblastoma via inactivation of YAP signaling pathway.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 25, 2022

Crosstalk between enteric serotonergic neurons and colorectal cancer stem cells to initiate colorectal tumorigenesis.

Crosstalk between enteric serotonergic neurons and colorectal cancer stem cells to initiate colorectal tumorigenesis.

Journal: Frontiers in oncology

Published: September 27, 2022

Irigenin inhibits glioblastoma progression through suppressing YAP/β-catenin signaling.

Irigenin inhibits glioblastoma progression through suppressing YAP/β-catenin signaling.

Journal: Frontiers in pharmacology

Published: August 25, 2022

Showing 1-12 of 19

Last Updated: 09/26/2026